Interrogation of Exosome-mediated Intercellular Signaling in Patients With Pancreatic Cancer

Clinical trial NCT02393703 · RECRUITING

Trial details

NCT number: NCT02393703
Sponsor: Memorial Sloan Kettering Cancer Center
Status: RECRUITING
Study type: OBSERVATIONAL

Pancreatic Cancer Benign Pancreatic Disease

Start date: 2015-03-01
Primary completion: 2027-03-01
Enrollment: 181

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.